{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:11:14Z","timestamp":1782857474783,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T00:00:00Z","timestamp":1538697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain\/MINDS) from Japan Agency for Medical Research and development","award":["JP17dm0207057h0001"],"award-info":[{"award-number":["JP17dm0207057h0001"]}]},{"name":"JSPS KAKENHI","award":["15K18330"],"award-info":[{"award-number":["15K18330"]}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K14929"],"award-info":[{"award-number":["17K14929"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12035-018-1366-4","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T17:54:15Z","timestamp":1538762055000},"page":"4203-4214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Effects of Neutralizing Antibody Production on AAV-PHP.B-Mediated Transduction of the Mouse Central Nervous System"],"prefix":"10.1007","volume":"56","author":[{"given":"Yoichiro","family":"Shinohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Konno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Suwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiju","family":"Hiromura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0721-4293","authenticated-orcid":false,"given":"Hirokazu","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"issue":"3685","key":"1366_CR1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1126\/science.149.3685.754","volume":"149","author":"RW Atchison","year":"1965","unstructured":"Atchison RW, Casto BC, Hammon WM (1965) Adenovirus-associated defective virus particles. Science (New York, NY) 149(3685):754\u2013756","journal-title":"Science (New York, NY)"},{"key":"1366_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-61779-370-7_1","volume":"807","author":"MD Weitzman","year":"2011","unstructured":"Weitzman MD, Linden RM (2011) Adeno-associated virus biology. Methods Mol Biol (Clifton, NJ) 807:1\u201323. \n                    https:\/\/doi.org\/10.1007\/978-1-61779-370-7_1","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"key":"1366_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jconrel.2016.09.011","volume":"241","author":"J Saraiva","year":"2016","unstructured":"Saraiva J, Nobre RJ, Pereira de Almeida L (2016) Gene therapy for the CNS using AAVs: the impact of systemic delivery by AAV9. J Control Release 241:94\u2013109. \n                    https:\/\/doi.org\/10.1016\/j.jconrel.2016.09.011","journal-title":"J Control Release"},{"key":"1366_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.coviro.2016.08.003","volume":"21","author":"A Srivastava","year":"2016","unstructured":"Srivastava A (2016) In vivo tissue-tropism of adeno-associated viral vectors. Curr Opin Virol 21:75\u201380. \n                    https:\/\/doi.org\/10.1016\/j.coviro.2016.08.003","journal-title":"Curr Opin Virol"},{"issue":"12","key":"1366_CR5","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1089\/hum.2016.090","volume":"27","author":"Jason Arsenault","year":"2016","unstructured":"Arsenault J, Gholizadeh S, Niibori Y, Pacey LK, Halder SK, Koxhioni E, Konno A, Hirai H et al (2016) FMRP expression levels in mouse central nervous system neurons determine behavioral phenotype. Hum Gene Ther 27(12):982\u2013996. \n                    https:\/\/doi.org\/10.1089\/hum.2016.090","journal-title":"Human Gene Therapy"},{"key":"1366_CR6","doi-asserted-by":"publisher","first-page":"14032","DOI":"10.1038\/mtm.2014.32","volume":"1","author":"Fathul Huda","year":"2014","unstructured":"Huda F, Konno A, Matsuzaki Y, Goenawan H, Miyake K, Shimada T, Hirai H (2014) Distinct transduction profiles in the CNS via three injection routes of AAV9 and the application to generation of a neurodegenerative mouse model. Mol Ther Methods Clin Dev Article number: 14032. \n                    https:\/\/doi.org\/10.1038\/mtm.2014.32","journal-title":"Molecular Therapy - Methods & Clinical Development"},{"key":"1366_CR7","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s12035-016-9777-6","volume":"54","author":"Y Matsuzaki","year":"2016","unstructured":"Matsuzaki Y, Konno A, Mukai R, Honda F, Hirato M, Yoshimoto Y, Hirai H (2016) Transduction profile of the marmoset central nervous system using adeno-associated virus serotype 9 vectors. Mol Neurobiol 54:1745\u20131758. \n                    https:\/\/doi.org\/10.1007\/s12035-016-9777-6","journal-title":"Mol Neurobiol"},{"issue":"11","key":"1366_CR8","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/mt.2011.157","volume":"19","author":"Adam K Bevan","year":"2011","unstructured":"Bevan AK, Duque S, Foust KD, Morales PR, Braun L, Schmelzer L, Chan CM, McCrate M et al (2011) Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders. Mol Ther 19(11):1971\u20131980. \n                    https:\/\/doi.org\/10.1038\/mt.2011.157","journal-title":"Molecular Therapy"},{"issue":"6","key":"1366_CR9","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/mt.2011.72","volume":"19","author":"SJ Gray","year":"2011","unstructured":"Gray SJ, Matagne V, Bachaboina L, Yadav S, Ojeda SR, Samulski RJ (2011) Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol Ther 19(6):1058\u20131069. \n                    https:\/\/doi.org\/10.1038\/mt.2011.72","journal-title":"Mol Ther"},{"issue":"4","key":"1366_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/hum.2011.200","volume":"23","author":"Lluis Samaranch","year":"2012","unstructured":"Samaranch L, Salegio EA, San Sebastian W, Kells AP, Foust KD, Bringas JR, Lamarre C, Forsayeth J et al (2012) Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther 23(4):382\u2013389. \n                    https:\/\/doi.org\/10.1089\/hum.2011.200","journal-title":"Human Gene Therapy"},{"issue":"2","key":"1366_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nbt.3440","volume":"34","author":"Benjamin E Deverman","year":"2016","unstructured":"Deverman BE, Pravdo PL, Simpson BP, Kumar SR, Chan KY, Banerjee A, Wu WL, Yang B et al (2016) Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat Biotechnol 34(2):204\u2013209. \n                    https:\/\/doi.org\/10.1038\/nbt.3440","journal-title":"Nature Biotechnology"},{"key":"1366_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.omtm.2017.07.006","volume":"6","author":"K Nitta","year":"2017","unstructured":"Nitta K, Matsuzaki Y, Konno A, Hirai H (2017) Minimal Purkinje cell-specific PCP2\/L7 promoter virally available for rodents and non-human primates. Mol Ther Methods Clin Dev 6:159\u2013170. \n                    https:\/\/doi.org\/10.1016\/j.omtm.2017.07.006","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"8","key":"1366_CR13","doi-asserted-by":"publisher","first-page":"e0162023","DOI":"10.1371\/journal.pone.0162023","volume":"11","author":"Y Shinohara","year":"2016","unstructured":"Shinohara Y, Konno A, Takahashi N, Matsuzaki Y, Kishi S, Hirai H (2016) Viral vector-based dissection of marmoset GFAP promoter in mouse and marmoset brains. PLoS One 11(8):e0162023. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0162023","journal-title":"PLoS One"},{"issue":"9","key":"1366_CR14","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/glia.22536","volume":"61","author":"S Yeo","year":"2013","unstructured":"Yeo S, Bandyopadhyay S, Messing A, Brenner M (2013) Transgenic analysis of GFAP promoter elements. Glia 61(9):1488\u20131499. \n                    https:\/\/doi.org\/10.1002\/glia.22536","journal-title":"Glia"},{"issue":"5-6","key":"1366_CR15","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s12311-017-0866-5","volume":"16","author":"Yoichiro Shinohara","year":"2017","unstructured":"Shinohara Y, Ohtani T, Konno A, Hirai H (2017) Viral vector-based evaluation of regulatory regions in the neuron-specific enolase (NSE) promoter in mouse cerebellum in vivo. Cerebellum (London, England). \n                    https:\/\/doi.org\/10.1007\/s12311-017-0866-5","journal-title":"The Cerebellum"},{"key":"1366_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.neulet.2017.11.049","volume":"665","author":"Y Matsuzaki","year":"2018","unstructured":"Matsuzaki Y, Konno A, Mochizuki R, Shinohara Y, Nitta K, Okada Y, Hirai H (2018) Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain. Neurosci Lett 665:182\u2013188. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2017.11.049","journal-title":"Neurosci Lett"},{"issue":"4","key":"1366_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/gt.2017.14","volume":"24","author":"L Samaranch","year":"2017","unstructured":"Samaranch L, Blits B, San Sebastian W, Hadaczek P, Bringas J, Sudhakar V, Macayan M, Pivirotto PJ et al (2017) MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain. Gene Ther 24(4):253\u2013261. \n                    https:\/\/doi.org\/10.1038\/gt.2017.14","journal-title":"Gene Therapy"},{"issue":"3","key":"1366_CR18","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ymthe.2018.01.018","volume":"26","author":"J Hordeaux","year":"2018","unstructured":"Hordeaux J, Wang Q, Katz N, Buza EL, Bell P, Wilson JM (2018) The neurotropic properties of AAV-PHP.B are limited to C57BL\/6J mice. Mol Ther 26(3):664\u2013668. \n                    https:\/\/doi.org\/10.1016\/j.ymthe.2018.01.018","journal-title":"Mol Ther"},{"issue":"12supp","key":"1366_CR19","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/nrmicro2460","volume":"8","author":"Maria G. Guzman","year":"2010","unstructured":"Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A et al (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8(12 Suppl):S7\u2013S16. \n                    https:\/\/doi.org\/10.1038\/nrmicro2460","journal-title":"Nature Reviews Microbiology"},{"issue":"45","key":"1366_CR20","doi-asserted-by":"publisher","first-page":"18476","DOI":"10.1073\/pnas.1112758108","volume":"108","author":"L Jiang","year":"2011","unstructured":"Jiang L, Zhang H, Dizhoor AM, Boye SE, Hauswirth WW, Frederick JM, Baehr W (2011) Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse model. Proc Natl Acad Sci U S A 108(45):18476\u201318481. \n                    https:\/\/doi.org\/10.1073\/pnas.1112758108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"1366_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1089\/humc.2017.010","volume":"28","author":"Yoshihide Sehara","year":"2017","unstructured":"Sehara Y, Fujimoto KI, Ikeguchi K, Katakai Y, Ono F, Takino N, Ito M, Ozawa K et al (2017) Persistent expression of dopamine-synthesizing enzymes 15 years after gene transfer in a primate model of Parkinson\u2019s disease. Human gene therapy Clinical development 28(2):74\u201379. \n                    https:\/\/doi.org\/10.1089\/humc.2017.010","journal-title":"Human Gene Therapy Clinical Development"},{"key":"1366_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2017.00101","volume":"11","author":"A Bacyinski","year":"2017","unstructured":"Bacyinski A, Xu M, Wang W, Hu J (2017) The Paravascular pathway for brain waste clearance: current understanding, significance and controversy. Front Neuroanat 11:101. \n                    https:\/\/doi.org\/10.3389\/fnana.2017.00101","journal-title":"Front Neuroanat"},{"issue":"9","key":"1366_CR23","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1172\/jci90603","volume":"127","author":"A Louveau","year":"2017","unstructured":"Louveau A, Plog BA, Antila S, Alitalo K, Nedergaard M, Kipnis J (2017) Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Invest 127(9):3210\u20133219. \n                    https:\/\/doi.org\/10.1172\/jci90603","journal-title":"J Clin Invest"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1366-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-018-1366-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-018-1366-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T13:32:37Z","timestamp":1589895157000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-018-1366-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1366"],"URL":"https:\/\/doi.org\/10.1007\/s12035-018-1366-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]},"assertion":[{"value":"23 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}